Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-24 @ 3:48 PM
NCT ID:
NCT00103792
Eligibility Criteria:
Inclusion Criteria:
* First or second relapse ANCA-associated vasculitis
* PR3- or MPO-ANCA antibodies present or histological proof of relapse
* Adult
Exclusion Criteria:
* Severe alveolar bleeding or (imminent) respiratory failure
* Renal failure (serum creatinine \>500 umol/L or dialysis)
* Maintenance therapy before start of study consisting of: cyclophosphamide \> 100 mg/day or prednisolone \>25 mg/day
* Intolerance or allergy for cyclophosphamide, mycophenolate mofetil or azathioprine
* Gravidity or inadequate anticonception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00103792
Study Brief:
Protocol Section:
NCT00103792